• Patients with diabetes carry a residual risk of cardiovascular, cancer, and mortality events after bariatric surgery: compared with patients without diabetes, the risk is 26%, 21%, 42%, and 61% higher for all-cause mortality, cancer, heart failure, and stroke, respectively, and double for myocardial infarction.
| INTRODUCTION
The latest global estimates from 2016 indicate that obesity is increasing rapidly, with over 650 million obese people worldwide. 1 In 2014, the prevalence of obesity in the UK and US was 26% 2 and 36.5%, 3 respectively. Bariatric surgery is an effective treatment for weight loss in severe cases of obesity 4, 5 and has been shown to reduce the risk of cardiovascular disease (CVD) and mortality in obese people. [6] [7] [8] [9] Results from the Swedish Obese Subjects study also demonstrated a reduction in the incidence of type 2 diabetes mellitus (T2DM) after bariatric surgery and improvements in glycemic control. 4 More recent data from Sweden show a reduction in all-cause mortality and cardiovascular events after bariatric surgery compared with obese patients with diabetes who did not undergo surgery. 10 However, it is unclear whether the presence of diabetes before surgery alters the association of bariatric surgery with cardiovascular and mortality outcomes. The Longitudinal Assessment of Bariatric Surgery -1 study found no independent association of diabetes on a composite outcome at 30 days (including death, deep vein thrombosis, pulmonary embolism, any intervention, and hospital stay) in the presence of other risk factors. 11 In contrast, data from the Italian Society of Obesity Surgery (SICOB), including 13 431 patients, found a low risk of early mortality following a bariatric procedure, although the risk in patients with diabetes was double that of patients without diabetes. 12 International guidelines recommend bariatric surgery for adults with a body mass index (BMI) of ≥40 kg/m 2 , or in those with a BMI between 35 and 40 kg/m 2 in the presence of other significant diseases including T2DM. [13] [14] [15] In light of these guidelines and the limited and inconsistent previous findings on mortality outcomes after bariatric surgery in the presence of pre-existing diabetes, we aimed to examine all-cause and cardiovascular mortality and the incidence of cardiovascular and cancer events following bariatric surgery in adults with and without pre-existing diabetes in England, and to estimate the risk of all-cause mortality following bariatric surgery in people with and without diabetes compared with the general population. Information  Table S1 ). Each participant entered the study on the date of admission for bariatric surgery after 1 April 2006 and was censored at the date of the outcome of interest or the end of the follow-up (i.e. 1 April 2014). Patients with baseline CVD or gastric cancer were excluded from the analysis. Preexisting diabetes was defined by ICD-10 codes E10-E14 on or before the index date. Because only pseudonymized information was used in this study, ethics approval was not needed.
| Main outcome measures
The main outcomes assessed in this study were all-cause mortality and CVD mortality. Information on in-hospital deaths was extracted from "discharge method" information in the HES, which was further supplemented by ONS linkage. All other deaths were extracted from the ONS. The cause of death was considered to be cardiovascular if the underlying cause of death was a cardiovascular event (Supporting Information Table S2 ). We also assessed the incidence of cardiovascular events, including myocardial infarction (MI), unstable angina, stroke, heart failure and cancer (for code lists, see Supporting Information Table S1 ).
| Statistical analysis
Participant characteristics were described using proportions and were compared between people with and without preexisting diabetes using Chi-squared tests. Average follow-up time overall and by diabetes status was calculated. Time-toevent for all-cause mortality, cardiovascular mortality, and incidence of MI, unstable angina, stroke, heart failure, and cancer were compared between people with and without preexisting diabetes using Kaplan-Meier survival curves, and survival distributions were compared using a log-rank test. Cox proportional hazards models were used to calculate hazard ratios (HR) and 95% confidence intervals (CIs) comparing people with and without pre-existing diabetes, adjusting for age, sex, index of multiple deprivation (IMD) score, ethnicity, geographic region, procedure type, and Charlson comorbidity index (an index to define comorbidities in patients) modified to exclude pre-existing diabetes; effect modification by procedure type was also assessed. Proportional hazards assumption was checked using Schoenfeld residuals. Risk for all-cause mortality at 30 days was estimated using the same method as above. Finally, we used the mortality data stratified by age for England and Wales in 2015 (https://www.ons.gov.uk/, accessed 19 May 2017) and corresponding events and person-years in our dataset to estimate, using negative binomial regression, all-cause mortality rate ratios following bariatric surgery in people with and without pre-existing diabetes compared with the general population.
| Sensitivity analysis
A restricted definition of bariatric surgery was used including codes only for primary operations (Supporting Information Table S2 ), and the HR was recalculated because participants with revision or secondary operations may be at a higher risk of adverse events due to the revision of surgery. Finally, a sensitivity analysis was performed in which the definition of bariatric surgery was restricted to only include codes used exclusively for bariatric surgery (Supporting Information Table S2 ).
| RESULTS

| Participant characteristics
In all, 38 060 people underwent a bariatric surgery procedure between April 2006 and March 2014. After excluding participants with baseline CVD, gastric cancer, or a gastric bubble or balloon procedure (n = 1552) and those with missing information on age or sex or with residence recorded as outside of England (n = 634), 35 887 participants remained, of which 9175 (25.6%) had a record of diabetes at the time of bariatric surgery. Approximately 85% of the bariatric surgery procedures were performed in participants aged between 30 and 59 years ( Table 1 ). The proportion of women with pre-existing diabetes undergoing bariatric surgery was slightly lower than those without diabetes (68.1% vs 80.7%, respectively) and 31.0% of patients undergoing bariatric surgery were from the most deprived areas, compared with 10.6% from the least deprived areas. People with pre-existing diabetes had a higher Charlson comorbidity score than people without diabetes (4.2% of people in the diabetes group had a Charlson score ≥ 5 vs 1.6% of people without diabetes). Bypass procedures constituted half of all bariatric procedures (Supporting Information  Table S3 ); however, people with pre-existing diabetes had a higher proportion of bypass procedures and a lower proportion of gastric banding than people without diabetes (55.2% vs 50.1% and 19.9% vs 24.1%, respectively).
| All-cause and cardiovascular mortality
During a mean (AESD) follow-up of 5.3 AE 2.0 years, there were 801 deaths, of which 293 (36.6%) were in people with pre-existing diabetes and 508 (63.4%) in people without. There was no significant difference in 30-day mortality following bariatric surgery according to diabetes status (adjusted HR comparing people with vs without diabetes 1.58; 95% CI 0.90-2.77). In people with pre-existing diabetes, the incidence of all-cause mortality was 6.3 per 1000 person-years (95% CI 5.6-7.1), compared with 3.5 per 1000 person-years (95% CI 3.2-3.8) in people without (Supporting Information Figure S1 ). For long-term mortality, KaplanMeier curves revealed a greater mortality risk in people with than without pre-existing diabetes (P < 0.001; Figure 1 ). After adjusting for age, sex, IMD score, ethnicity, geographic region, Charlson comorbidity index, and procedure type, the risk of all-cause mortality in people with preexisting diabetes was 26% higher than in those without diabetes (HR 1.26; 95% CI 1.08-1.46; Figure 2 ). There was no interaction in the association between diabetes status and mortality by procedure type (P interaction = 0.344). There were only 50 CVD deaths, of which 16 (32.0%) were in the diabetes group. Further multivariable analyses were not performed in this cohort due to the small number of events in the diabetes group.
| Cardiovascular events and cancer
Incidence in people without and with pre-existing diabetes ranged from 0.3 and 1.5 per 1000 person-years, respectively, for MI to 5.0 and 8.4 per 1000 person-years, respectively, for cancer (Supporting Information Figure S1 ). Of the 121 incident MIs, 71 (58.7%) were reported in people with pre-existing diabetes. In the multivariable analysis, preexisting diabetes was associated with a greater than 2-fold increase in the risk of MI after bariatric surgery (HR 2.08; 95% CI 1.42-3.05; Figure 2 Figure 2 ).
| Mortality compared with the general population
Age-specific mortality rates in people with pre-existing diabetes who underwent bariatric surgery were higher than mortality rates in the general population for younger ages, with progressively lower differences in older people (Supporting Information Figure S2 ; Figure 3 ). People without pre-existing diabetes who underwent bariatric surgery had a 35% increased risk of all-cause mortality than the general population (age-standardized mortality rate ratio 1.35; 95% CI 1.23-1.48; Figure 3 ). In comparison, people with pre-existing diabetes and bariatric surgery had a 70% increased risk of all-cause mortality than the general population (age-standardized mortality rate ratio 1.70; 95% CI 1.52-1.91; Figure 3 ).
| Sensitivity analyses
The estimates remained similar to the main analysis when the definition of bariatric surgery was restricted to only include primary procedure codes. Similarly, when restricting the definition of bariatric surgery to only codes used exclusively for bariatric surgery, the risk of all-cause mortality in the diabetes group was 33% higher than that in the nondiabetes group (HR 1.33; 95% CI 1.10-1.60; Supporting Information Table S4 ).
| DISCUSSION
| Principal findings
In the present large, population-based study, we found the risk of all-cause mortality to be 26% higher after bariatric surgery in people with pre-existing diabetes than in those without diabetes. The risk of all cardiovascular outcomes, including MI, stroke, unstable angina, and heart failure, was also greater in adults with pre-existing diabetes, with the risk of MI being over twice as high in adults with pre-existing diabetes than in people without diabetes. Similarly, the rate of cancer was 21% higher following bariatric surgery in people with pre-existing diabetes than in people without
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| Strengths and limitations
To our knowledge, the present study is the largest to comprehensively examine the risk of mortality and other complications following bariatric surgery by diabetes status. Data from the HES captured diagnoses, procedures, and other comorbidities for all hospital admissions in England, and mortality data were further confirmed through linkage with the ONS, hence the outcome ascertainment in this study was robust. However, these data are primarily collected for administrative and financial purposes. Therefore, we did not have information on baseline BMI or the change in BMI after bariatric surgery or HbA1c before surgery. Nevertheless, in the UK, until 2014 bariatric surgery was only offered to people with a BMI of ≥40 kg/m 2 , or between 35 and 40 kg/m 2 in the presence of other significant disease, including diabetes. 13 A study including 756 patients undergoing bariatric surgery at Brigham and Women's Hospital, Boston, found the mean (AESD) BMI to be 47.0 AE 6.8 and 47.0 AE 7.3 kg/m 2 in people with and without diabetes, respectively, with no significant difference between the two groups. 16 Therefore, we believe the BMI of participants in the present study was at least 35 kg/m 2 . In addition, due to the nature of data collection for the HES, we did not have information on the duration and severity of diabetes or glycemic control before and after bariatric surgery, and residual confounding may be present. Furthermore, owing to similar limitations of data recording, we could not further stratify the group without diabetes into euglycemia and prediabetes. We included all codes for diabetes rather than specific T2DM because the type of diabetes is not very well phenotyped in the HES and some patients have codes for both type 1 diabetes mellitus and T2DM over time. 17 Nevertheless, approximately 85% of participants were identified as having T2DM. 17 Finally, when comparing age-specific mortality rates with those of the general population, we could only include ages 35 to 74 years because the number of events in other age groups was either very small or nil.
| Comparison with current literature
We found that despite no significant difference in 30-day mortality, the risk of long-term mortality and CVD outcomes following bariatric surgery was higher in people with than without pre-existing diabetes. The Emerging Risk Factors Collaboration study including 123 205 deaths among 820 900 people found that people with diabetes have a 70% higher risk of death from any cause compared with people without diabetes. 18 The findings of the present study support a similar hypothesis, whereby people with diabetes who undergo bariatric surgery are still at higher risk of all-cause mortality and other outcomes than those without diabetes, despite similar short-term mortality and biochemical and anthropometric improvements that take place after bariatric surgery. 4 Therefore, people with diabetes who undergo bariatric surgery may need closer monitoring, well-beyond the first year after surgery. Currently, there are no studies comparing long-term mortality and CVD outcomes following bariatric surgery between people with and without pre-existing diabetes. Nevertheless, data from SICOB including 34 deaths within the first 60 days following 13 431 bariatric surgery procedures found a significant difference between the mortality proportions by diabetes status (i.e. 0.4% of participants without diabetes died within the first 60 days vs 0.8% of participants with diabetes). 12 One potential explanation of our findings could be a higher number of existing comorbidities in people with diabetes, because the risk of mortality after adjusting for the Charlson comorbidity index was 26%. Another potential explanation could be the metabolic "memory" phenomenon, whereby following a prolonged duration of diabetes the complications persist and progress despite adequate glycemic control. 19 This phenomenon has been seen in many trials involving patients with T2DM, including the UK Prospective Diabetes Study (UKPDS) 20 and several other studies. [21] [22] [23] The degree of weight loss is known to be the major driver for improvements in cardiovascular risk factors, 24, 25 as well as glycemic improvement. 26 A study using data from 3193 patients with gastric bypass from the Virginia Commonwealth University Medical Center found that after 1 year of surgery, people with diabetes had significantly lower weight loss and higher BMI than people without diabetes, 27 which may potentially explain why people with diabetes in the present study had worse outcomes than people without diabetes. A study including 78 morbidly obese, non-operated patients with T2DM found that the mortality rate was 28%. 28 In comparison, crude all-cause mortality in the diabetes group undergoing bariatric surgery in the present study was 3.19%. Therefore, although the rate of allcause mortality after bariatric surgery in people with T2DM is significantly higher than in the general population, the rate is considerably lower in relation to non-operated obese T2DM patients.
In participants with and without diabetes, we found a low ratio of cardiovascular to all-cause mortality: deaths from CVD accounted only for 6.2% of all-cause deaths (5.5% and 6.7% in participants with and without pre-existing diabetes, respectively), which is lower than values for the general population. Our estimate is also lower than estimates reported in previous studies of patients who underwent bariatric surgery, which ranged from 15.9% to 42.6%. 7, 10, 29 Heterogeneity in the populations included, along with differences in the definition of the underlying cause of death (through ICD-10 codes) and in healthcare systems, and dissimilar study calendar time (period effect) and duration, could explain the smaller ratio of cardiovascular to all-cause mortality found in the present study. However, a larger proportion of non-cardiovascular deaths has been already reported in obese subjects with diabetes: the relationship between BMI and cardiovascular death differs from that between BMI and all-cause death, particularly for high levels of BMI, and is likely related to an increased risk of cancer death. 30 From this perspective, our findings extend previous observations also in subjects with diabetes who underwent bariatric surgery.
| Conclusion
Using the largest population-based cohort of bariatric surgery patients to date, we found that despite the reported improvements in biomarkers and outcomes after surgery, and no significant difference in 30-day mortality between people with and without diabetes, people with diabetes carry a residual risk of adverse CVD outcomes and mortality, suggesting that patients with pre-existing diabetes may need closer monitoring and risk factor control in clinical care following bariatric surgery. Further studies should explore the potential reasons for this excessive risk in people with diabetes. Moreover, based on our findings, patients with preexisting diabetes undergoing bariatric surgery should be made aware of such residual risk before the procedure. In addition, it should be recognized that, in patients without diabetes, the risk of death after surgery remains higher than that of the general population.
